PP

Poolakka Param Ban Shamsudheen

Active Director Designated Partner DIN 11065992
DIN 11065992 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Poolakka Param Ban Shamsudheen

Data last updated:

Poolakka Param Ban Shamsudheen is a Designated Partner at Gsr Eye Care Hospital Llp (since 2025). The company operates in Healthcare.

DIN 11065992
Primary Designation Designated Partner
Industry Healthcare
First Appointment 20 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Apr 20252025Active

Board colleagues of Poolakka Param Ban Shamsudheen

NameDINCompanyDesignation
Mohammed Rafi11065991Gsr Eye Care Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Gsr Eye Care Hospital Llp
Premium access

Shareholding and investment profile for Poolakka Param Ban Shamsudheen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poolakka Param Ban Shamsudheen

Poolakka Param Ban Shamsudheen currently holds 1 directorship: Gsr Eye Care Hospital Llp (Designated Partner, since 20 Apr 2025).

Poolakka Param Ban Shamsudheen was first appointed on 20 Apr 2025 as Designated Partner at Gsr Eye Care Hospital Llp.

The current boards of Poolakka Param Ban Shamsudheen's companies include Mohammed Rafi (Gsr Eye Care Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available